SEI Investments’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-247
Closed -$52K 2408
2019
Q1
$52K Buy
+247
New +$46.3K ﹤0.01% 2614
2017
Q3
Sell
-78
Closed -$21K 3195
2017
Q2
$21K Hold
78
﹤0.01% 2436
2017
Q1
$19K Hold
78
﹤0.01% 2339
2016
Q4
$16K Hold
78
﹤0.01% 2375
2016
Q3
$21K Hold
78
﹤0.01% 2264
2016
Q2
$11K Buy
+78
New +$10.5K ﹤0.01% 2249
2015
Q4
Sell
-1,322
Closed -$214K 2527
2015
Q3
$214K Buy
+1,322
New +$286K ﹤0.01% 1585

Other funds holding AXDX

SEI Investments's AXDX Position: Q2 2019 in Review

SEI Investments sold out of Accelerate Diagnostics (AXDX) in Q2 2019, closing a stake of 247 shares — an estimated $52K sold.

SEI Investments first reported a position in AXDX in Q3 2015 and held it in 7 quarters. The position peaked at $214K in Q3 2015. 117 funds tracked by Wall St. Rank hold AXDX as of Q2 2019.

  • SEI Investments reported no remaining Accelerate Diagnostics position as of Q2 2019 after selling out during the quarter.
  • SEI Investments sold 247 Accelerate Diagnostics shares in Q2 2019, an estimated $52K.
  • SEI Investments first reported a position in Accelerate Diagnostics in Q3 2015 and held it in 7 quarters.
  • SEI Investments's Accelerate Diagnostics position peaked at $214K in Q3 2015.
  • 117 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2019.

Based on SEI Investments's 13F filing for Q2 2019, filed 14 Aug 2019.